Artiva Biotherapeutics (NASDAQ:ARTV) Rating Increased to Buy at HC Wainwright
Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report) was upgraded by equities researchers at HC Wainwright to a “buy” rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm presently has a $12.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 485.37% from the […]
Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report) was upgraded by equities researchers at HC Wainwright to a “buy” rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm presently has a $12.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 485.37% from the […]
